Harnessing immunomodulation during DNA damage in Ewing sarcoma

Ewing sarcoma is a fusion-oncoprotein-driven primary bone tumor most commonly diagnosed in adolescents. Given the continued poor outcomes for patients with metastatic and relapsed Ewing sarcoma, testing innovative therapeutic approaches is essential. Ewing sarcoma has been categorized as a ‘BRCAness...

Descripción completa

Detalles Bibliográficos
Autores principales: Daley, Jessica D., Olson, Adam C., Bailey, Kelly M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722957/
https://www.ncbi.nlm.nih.gov/pubmed/36483025
http://dx.doi.org/10.3389/fonc.2022.1048705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722957/
https://www.ncbi.nlm.nih.gov/pubmed/36483025
http://dx.doi.org/10.3389/fonc.2022.1048705

Ejemplares similares